Quiz 3 Flashcards
Most common cancer in women, 1 in 8 women will get this
29-30% of new cancers in women
2017: 255,180 new cases (over 252,000 females, 24-2,500 males)
African American women more likely to present with regional/distant disease than white women
Family member with bilateral disease or diagnosed premenopause increases risk
Left most common
Treated with tangents, IMRT, or hybrid of both; usually chemo first
Stop using birth control
Rare to other breast (mets 0.5-1%) but 1-2 times more likely to develop new tumor in contralateral breast
Ovaries, spleen, and stomach
TNM staging
Breast cancer
10 risk factors of breast cancer
Gender: female increases risk
Early menarche
Increased age of birth of first child
Late menopause over 50-55 years old
Use of exogenous hormones: birth control increases risk with prolonged use over 5 years
History of atypical hyperplasia
Family history
Radiation exposure: avoid wedge because of scatter
Increasing age and history of breast cancer
Obesity/high fatty diets: fat cells produce estrogen
Menarche
Menstration
Benign breast disease proliferates and turn malignant
Atypical hyperplasia
___-___% of breast cancer occurs from altered genes
BRCA 1 & 2 mutations account for ___-___% of breast cancer
1 first degree relative with disease increases risk, 2 _______ risk
5-10%
5-6%
Triples
Protein promotes growth of breast cancer, 1 in 5 cancers have this more aggressive mutation
Human epidermal growth factor receptor 2 (HER2)
6 signs and symptoms of breast cancer
Most common sign of early benign disease: non-painful, mobile mass; malignant: firm, nontender, irregular, non-movable and fixed mass
Skin dimpling
Nipple retraction
Erythema coincides with peau d’orange
Nipple discharge
Enlarged axillary/supraclavicular (scv) LN
Dimpling on the skin commonly mistaken as infection, 50% have lump or mass
Clinical/pathological diagnosis, can be lymphatic
Peau d’orange/inflammatory
Upper outer breast cancer = \_\_\_% Upper inner = \_\_\_% Central = \_\_\_% Lower outer = \_\_\_% Lower inner = \_\_\_%
Upper outer breast cancer = 50% Upper inner = 15% Central = 17% Lower outer = 11% Lower inner = 6%
7 diagnostic methods for breast cancer
Mammogram Biopsy: fine needle; guided biopsy (mammotome/stereotactic biopsy) for deep tumor Breast self examinations (BSE) Clinical self exam (CBE) Digital radiography MRI defines extent of disease PET for staging
When is it recommended for patients 40-44 years old, 45-54 years old, and 55 or older to get a mammogram?
40-44: patient’s choice
45-54: yearly
55: every 2 years
Excision of tumor with small margin of normal tissue around it; with LN dissection and RT, gets as good a result as mastectomy
Excisional, remove mass in breast
Lumpectomy
Median age of diagnosis of breast cancer
61
8 histologic types of breast cancers
Invasive/infiltrating ductal Infiltrating lobular Medullary: 5-7% Tubular Mucinous Comedo Paget's disease Inflammatory/peau d'orange
70-80% of breast cancers; in ducts
Squamous, angiosarcoma, etc.
Invasive/infiltrating ductal
10-15% of breast cancers, second most common in glands that secrete milk
Infiltrating lobular
Uncommon disease of nipple
Paget’s disease
Average doubling time of breast cancer
60-90 days, but can be as fast as 15 days or up to 600 days
LN involvement in ___-___% of breast cancers
40-60%
Lateral lesions usually go to _______ or _______ LNs
Medial lesions usually go to _______, _______, or _______ LNs
Lateral lesions usually go to axillary or supraclavicular LNs
Medial lesions usually go to internal mammary, mediastinal, or supraclavicular LNs
Biopsy first LNs that receive drainage from tumor; if disease present, complete biopsy
Sentinel node biopsy
5 year survival of stage 1, 2, 3, and 4 breast cancer
1: 99%
2: 84%
3: 65%
4: less than 26%
60% estrogen receptor (ER) status; slower-growing, better prognosis
Usually postmenopausal
Use tamoxifen
ER positive
Anti-estrogen therapy, 60% response rate for ER positive
Standard adjuvant therapy for ER positive patients
Tamoxifen
More aggressive, postmenopausal women
ER negative
More aggressive and dividing breast cancer
Elevated S phase
Malignant cellular proliferation has not extended through basement membrane into surrounding tissue
Carcinoma in situ for breast cancer
Examine DNA count/microscopic particles to see amount of DNA
Flow cytometry
Unusual number of chromosomes, more aggressive
Aneuploid
3 surgical options for breast cancer
Lumpectomy
Axillary node dissection
Modified radical mastectomy
Removes all breast tissue and axillary node dissection; remove breast, LNs, and sentinel node biopsy
Modified radical mastectomy
4 things post-mastectomy radiation is recommended for
Patients with tumors over 5 cm
Skin or chest involvement
Positive surgical margins
Over 4 positive LNs
Intact breast and removed breast typical dose
Intact: 4680 cGy and 1400 cGy boost = 6080 cGy
Removed: 5040 cGy and 1000 cGy = 6040 cGy (initial dose higher because we don’t have to worry about cosmesis)
Chemo given to patients before surgery, have locally advanced or inflammatory breast cancer
Get tumor shrinkage, node negative less than 1 cm
Neoadjuvant
Chemo given after primary treatment, recommended for all with positive LNs
Adjuvant
3 side effects of tamoxifen
Increase calcium bone uptake (decrease osteoporosis)
Decrease cholesterol and heart disease
Increase risk of uterine tumors
7 common chemo drugs for breast cancer
Doxorubicin Epirubicin Paclitaxal Docetaxal 5FU Cyclophosphamide Methotrexate
2 factors for breast cancer patients to receive bone marrow transplant (BMT), have shown prolonged survival but still investigational
No mets
4 or less positive LNs
8 common sites of breast cancer mets (most to least common)
LN 40-76% Bone 71% Lung 69% Liver 65% Pleura 51% Adrenals 49% Skin 30% Brain
5 labs for breast cancer
CAAD Elevated CA 15-3 Serum liver function studies Bone scans Chest x-ray
5 things patients and families can suffer from
Depression Impaired marital relationships Lowered self-esteem Developmental delays in children Behavioral problems with adolescents
6% of all cancers, 8% of all cancer deaths
Third most common cancer for both genders, second leading cause of cancer deaths
Rate 50 times higher for people over 60-79 years old, environmental
Higher incidence in African Americans
Equal in men and women, rectal higher in men
Lower in people who have a lot of vegetables in diet, high fiber; 5 servings of fruit and vegetables a day
Direct extension most common, LN and blood, and implantation and seeding
Neoadjuvant chemo before surgery, 5FU radiosensitizes and enhances leucovorin
Colorectal cancer (CRC)
Median age of diagnosis of CRC
60-65 years old
Most common histology of CRC
Adenocarcinoma (90%) arises from constantly-secreting
65%, 25%, less than 10%, and less than 5% of anal cancers
65%: squamous
25%: transitional
Less than 10%: adenocarcinoma
Less than 5%: miscellaneous
9 contributing factors to CRC
Alcohol, especially beer Tobacco History of colon cancer Sedentary employment: inactive GYN radiation Inflammatory bowel disease (ex: Crohn's, etc.) Polyposis Family history Irritation of anal canal
3 irritations of anal canal
Condyloma
Rectal intercourse
Fistulas, tears/fissures, abscesses, hemorrhoids, etc.
Anal warts
Condyloma
Grade identifies adenocarcinoma: ___% of disease is well-differentiated, ___% moderately differentiated, and ___% poorly differentiated
10% of disease is well-differentiated
70% moderately differentiated
20% poorly differentiated
5 year survival for stage I, II, IIIA-C, and IV CRC
I: 93%
II: 85%
IIIA-C: 83-44%
IV: 8%
6 signs and symptoms of right/ascending colon disease
Abdominal pain Melena Weakness due to anemia, common Obstruction uncommon Palpable abdominal mass Anorexia
Bleeding dark or mahogany red
Melena
3 signs and symptoms of transverse colon disease
Blood in stool
Change in bowel pattern
Potential bowel obstruction
12 signs and symptoms of left/descending colon disease
Colicky pain Bleeding red mixed with stool Obstruction common Weakness due to anemia, uncommon Nausea and vomiting Constipation alternating with diarrhea Decreased caliber of stool Tenesmus Fatigue Anorexia Failure to thrive Right upper quadrant (RUQ) pain (common hepatic duct leads to liver mets)
Caliber
Size
Feeling you have to go to the bathroom due to narrowing, ineffective and painful straining during a bowel movement (BM)
Tenesmus
9 signs and symptoms of rectal disease
Steady pain Bleeding bright red, coating stool Change in bowel movements Pencil stools Rectal urgency Fecal incontinence Spasmodic contractions Peineal and buttock pain Tenesmus
4 signs and symptoms of anal disease
Bleeding
Pain
Sensation of a mass
Severe anal itching
6 signs and symptoms of CRC
Change in bowel habitus Blood in stool Abdominal pain Anorexia Flatulence Indigestion
3 late signs and symptoms of CRC
Weight loss
Fatigue
Decline in general health
CRC percent in descending and sigmoid, ascending, and transverse colon
Descending and sigmoid: 52%
Ascending: 32%
Transverse: 16%
Glycoprotein elevates with CRC
Carcinoembryonic antigen (CEA)
3 common sites of mets for colon
Liver: venous drainage through colon
Lungs
Peritoneum
Colon cancer goes through bowel wall and sheds into bowel cavity
Peritoneal seeding
Common mets site of rectal disease
Lung: venous drainage through hemorrhoidal veins
3 common sites of mets for anus
Liver
Lungs
Inguinal nodes
4 complications due to CRC
Bowel perforation
Obstruction of surrounding genitourinary organs
Hemorrhage
Liver failure